We are live on ! Find out more
EI

EAM Investors Portfolio holdings

AUM $866M
1-Year Est. Return 377.14%
This Fund
S&P 500
This Quarter Est. Return
+47.43%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.07%
10 Year Est. Return
+19,957,621.5%
AUM
$540M
AUM Growth
+$30.8M
Cap. Flow
-$71M
Cap. Flow %
-13.15%
Top 10 Hldgs %
9.77%
Holding
405
New
161
Increased
21
Reduced
59
Closed
149

Top Sells

Rank Stock Value
1
VKTX icon
Viking Therapeutics
VKTX
+$5.66M
2
HROW icon
Harrow
HROW
+$5.57M
3
PI icon
Impinj
PI
+$5.06M
4
CECO icon
Ceco Environmental
CECO
+$4.79M
5
PARR icon
Par Pacific Holdings
PARR
+$4.38M

Sector Composition

Rank Sector Weight
1 Healthcare 26.89%
2 Technology 25.18%
3 Industrials 23.68%
4 Consumer Discretionary 11.94%
5 Consumer Staples 3.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMAN
401
DELISTED
eMagin Corporation
EMAN
-720,020
Closed -$1.5M
KDNY
402
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
-48,875
Closed -$1.13M
ISEE
403
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
-90,079
Closed -$2.19M
RXDX
404
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
-30,201
Closed -$3.24M
SBDS
405
DELISTED
Solo Brands Inc
SBDS
-11,164
Closed -$3.21M

Similar funds

EAM Investors's Q2 2023 Portfolio in Review

As of Q2 2023, EAM Investors held 405 positions worth $540M, up 6% from $509M the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

EAM Investors withdrew a net $71M in Q2 2023, closing 149 positions and reducing 59 holdings. Its most notable exit was Viking Therapeutics, an estimated $5.66M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 25% a quarter earlier, followed by Technology and Industrials.

Against the trend, EAM Investors opened a new position in Applied Digital worth $7.24M.

  • EAM Investors's largest Q2 2023 buy was Applied Digital: 774,423 shares worth $7.24M.
  • EAM Investors added most to Arlo Technologies in Q2 2023, an estimated $2.35M increase.
  • EAM Investors's biggest Q2 2023 reduction was Harrow, cutting an estimated $5.57M.
  • EAM Investors fully exited Viking Therapeutics in Q2 2023, selling an estimated $5.66M.
  • EAM Investors's ten largest holdings make up 9.8% of its $540M portfolio in Q2 2023.
  • EAM Investors opened 161 new positions and closed 149 in Q2 2023.
  • EAM Investors's portfolio value rose 6% quarter-over-quarter to $540M.

Based on EAM Investors's 13F filing for Q2 2023, filed 11 Aug 2023.